|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0007131,
umls-concept:C0015295,
umls-concept:C0022877,
umls-concept:C0026882,
umls-concept:C0034802,
umls-concept:C0150108,
umls-concept:C0220825,
umls-concept:C0370003,
umls-concept:C0439810,
umls-concept:C0449438,
umls-concept:C0681935,
umls-concept:C1414313,
umls-concept:C1513778,
umls-concept:C1519249,
umls-concept:C1521991,
umls-concept:C1537502,
umls-concept:C1556084,
umls-concept:C2347026,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-30
|
|
pubmed:abstractText |
The Evaluation of the epidermal growth factor receptor (EGFR) Mutation status for the administration of EGFR-Tyrosine Kinase Inhibitors in non-small cell lung Carcinoma (NSCLC) (ERMETIC) project part 1 assessed the accuracy of EGFR and KRAS mutations detection in NSCLC among 15 French centers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:AntoineMartineM,
pubmed-author:BarbuVéroniqueV,
pubmed-author:Beau-FallerMichèleM,
pubmed-author:BiècheIvanI,
pubmed-author:BlonsHélèneH,
pubmed-author:BoyerJean-ChristopheJC,
pubmed-author:BrambillaElisabethE,
pubmed-author:BuisineMarie-PierreMP,
pubmed-author:CadranelJacquesJ,
pubmed-author:ChouaidChristosC,
pubmed-author:CouletFlorenceF,
pubmed-author:DanelClaireC,
pubmed-author:DegeorgesArmelleA,
pubmed-author:HainautPierreP,
pubmed-author:LizardSarabS,
pubmed-author:MauguenAudreyA,
pubmed-author:MichielsStefanS,
pubmed-author:MounawarMouniaM,
pubmed-author:OlschwangSylvianeS,
pubmed-author:PoulotVirginieV,
pubmed-author:PrétetJean-LucJL,
pubmed-author:Prunier-MirebeauDelphineD,
pubmed-author:RichardNicolasN,
pubmed-author:RollandEstelleE,
pubmed-author:SaulnierPatrickP,
pubmed-author:ZalcmanGérardG,
pubmed-author:de FraipontFlorenceF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1006-15
|
|
pubmed:meshHeading |
pubmed-meshheading:21532509-Adult,
pubmed-meshheading:21532509-Aged,
pubmed-meshheading:21532509-Aged, 80 and over,
pubmed-meshheading:21532509-Antineoplastic Agents,
pubmed-meshheading:21532509-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21532509-DNA Mutational Analysis,
pubmed-meshheading:21532509-Exons,
pubmed-meshheading:21532509-Female,
pubmed-meshheading:21532509-France,
pubmed-meshheading:21532509-Humans,
pubmed-meshheading:21532509-Laboratories,
pubmed-meshheading:21532509-Lung Neoplasms,
pubmed-meshheading:21532509-Male,
pubmed-meshheading:21532509-Middle Aged,
pubmed-meshheading:21532509-Mutation,
pubmed-meshheading:21532509-Paraffin Embedding,
pubmed-meshheading:21532509-Protein Kinase Inhibitors,
pubmed-meshheading:21532509-Proto-Oncogene Proteins,
pubmed-meshheading:21532509-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21532509-Reproducibility of Results,
pubmed-meshheading:21532509-Single-Blind Method,
pubmed-meshheading:21532509-ras Proteins
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
|
|
pubmed:affiliation |
Laboratoire de Biologie Moléculaire, Hôpital de Hautepierre, Strasbourg, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|
